At Reprogenetics, our personnel have been performing PGD since 1991 and were the first to develop PGD tests for aneuploidy and translocations. To date Reprogenetics has performed diagnosis of over 45,000 PGD cycles, more than any other PGD laboratory in the world. When performed by Reprogenetics, PGD significantly increases implantation rates and decreases spontaneous abortions. We have a record unmatched by any other Preimplantation Genetics Diagnosis reference center.
Reprogenetics was the first Laboratory, and still one of the few, to be licensed by the States of New York, California, Rhoda Island, Pennsylvania and Maryland Department of Health to perform Preimplantation Genetic Diagnosis for any indication (aneuploidy, translocations, or gene defects), which at present is the only agency in the US regulating PGD. Reprogenetics provides PGD services to more than 200 IVF centers in the US, including most of those with the best pregnancy outcomes. We are recognized as leaders in our industry, and we continue to innovate to help achieve the best outcomes for our patients.